NCM
Northside Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,380
| Closed | -$311K | – | 113 |
|
|
2022
Q3 | $311K | Hold |
4,380
| – | – | 0.1% | 66 |
|
|
2022
Q2 | $337K | Hold |
4,380
| – | – | 0.11% | 62 |
|
|
2022
Q1 | $320K | Hold |
4,380
| – | – | 0.09% | 68 |
|
|
2021
Q4 | $273K | Hold |
4,380
| – | – | 0.07% | 70 |
|
|
2021
Q3 | $259K | Hold |
4,380
| – | – | 0.07% | 77 |
|
|
2021
Q2 | $293K | Sell |
4,380
-160
| -4% | -$10.7K | 0.07% | 72 |
|
|
2021
Q1 | $287K | Buy |
4,540
+91
| +2% | +$5.75K | 0.08% | 68 |
|
|
2020
Q4 | $276K | Hold |
4,449
| – | – | 0.08% | 70 |
|
|
2020
Q3 | $268K | Sell |
4,449
-1,945
| -30% | -$117K | 0.09% | 72 |
|
|
2020
Q2 | $376K | Buy |
+6,394
| New | +$376K | 0.13% | 69 |
|
|
2018
Q3 | – | Sell |
-5,210
| Closed | -$288K | – | 58 |
|
|
2018
Q2 | $288K | Buy |
+5,210
| New | +$288K | 0.1% | 52 |
|
|
2017
Q2 | – | Sell |
-6,619
| Closed | -$360K | – | 71 |
|
|
2017
Q1 | $360K | Buy |
+6,619
| New | +$360K | 0.1% | 103 |
|